Net Sales Margin: Qilian International Holding (QLI)

Brandmark of Qilian International Holding Group Limited (QLI)

The net margin percentage demonstrates the efficiency of delegating raw material procurement to cooperatives, which minimizes supply risks for Qilian International (QLI). The business relies on government licensing and certified laboratories, creating a high barrier to entry. The -16.70 metric indicates the status of a company whose growth is constrained by strict PRC controls and a dependence on administrative resources within the traditional medicine sector.

qlsyy.net (QLI) Net Return on Sales: for the period 07/04/2022 - 08/17/2024

Summary analytical data breakdowns for Qilian International Corp (QLI)

- company stock exchange capitalization indicators:
Summary company analysis:Qilian International, QLI
Flagship merchandise of Qilian International Holding Group Limited

Net profit margin measures the portion of profit remaining after deducting all operating and non-operating expenses from revenue. For Qilian International (QLI), this metric reflects the efficiency of implementing robotic extraction lines for licorice raw materials. By analyzing the profit margin ratio, an investor can determine whether AI control systems are reducing costs. A divergence between revenue and profit growth rates signals inefficiency in capital expenditures, while a stable trend confirms the qualitative scaling of the business.

Competitor analysis for Qilian International

HLN: Net Sales Margin|Net Return on Sales KVUE|Net Margin veronapharma.com|Net Return on Sales MENS (Jyong Biotech Corp)|Net Margin Ligand (LGND)|Net Sales Margin amneal.com (AMRX)|Net Sales Margin PRGO (perrigo.com)|Alvotech SA (ALVO) - Net Margin|Liquidia Inc. - Net Sales Margin|Net Profitability Margin Galapagos Corp (GLPG)|ANI Pharmaceuticals (ANIP) - Net Margin|Net Return on Sales MNKD|Net Margin Amphastar Pharmaceuticals, Inc.|Pacira Pharmaceuticals (PCRX) - Company Sales Margin|Net Sales Margin SPRY|TBPH - Net Margin|Aquestive Pharma - Return on Sales by Net Profit|Net Sales Margin scpharmaceuticals.com SCPH|Tectonic - Net Sales Margin|TNXP - Net Sales Margin|SXTC: Net Sales Margin|Eupraxia Pharma - Net Profit Rate|BHST (bioharvest.com) - Net Sales Margin|Net Return on Sales EXOZ (invizyne.com)|Net Sales Margin ORMP|Company Sales Margin Entera Bio|Net Sales Margin HYFT (MindWalk Holdings, Inc.)|ABVC BioPharma - Net Margin|Cumberland Corp - Net Sales Margin|QNTM - Net Sales Margin|FibroGen, Inc. (FGEN) - Net Margin|TELO: Company Net Profitability|RANI (Rani Therapeutics Inc) - Net Sales Margin|Net Margin synergychc.com SNYR|Net Margin Rallybio Corp. (RLYB)|LEXX - Net Margin|Net Sales Margin PULM (pulmatrix.com)|Company Net Profitability PTHL (Pheton)|APM - Net Margin|Company Sales Margin Lyra Therapeutics Inc LYRA|impactbiomedinc.com (IBO) - Net Margin|TNF Pharma (TNFA) - Net Sales Margin|YCBD (cbdmd.com) - Net Sales Margin|Return on Sales by Net Profit PainReform (PRFX)|Net Margin Altamira Therapeutics (CYTO)|Company Sales Margin Lipella Pharma|Optinose - Return on Sales by Net Profit|Company Sales Margin pieris.com (PIRS)|PROC - Net Margin|Net Profit Margin PTPI|SLRN: Net Sales Margin|Return on Sales by Net Profit TFF Pharma